[1] Takeda T.Possible concurrence of TDP-43, tau and other proteins in amyotrophic lateral sclerosis/frontotemporal lobar degeneration[J].Neuropathology, 2018, 38:72-81. [2] Cui Z, Xu Y, Zhang LM.Research progress of TDP-43 and TDP-43 proteinopathies[J].Zhongguo Lin Chuang Shen Jing Ke Xue, 2016, 24:351-356.[崔政, 徐毅, 张黎明.反式激活应答DNA结合蛋白-43及其相关疾病的研究进展[J].中国临床神经科学, 2016, 24:351-356.] [3] Spires-Jones TL, Attems J, Thal DR.Interactions of pathological proteins in neurodegenerative diseases[J].Acta Neuropathol, 2017, 134:187-205. [4] Josephs KA, Murray ME, Whitwell JL, Tosakulwong N, Weigand SD, Petrucelli L, Liesinger AM, Petersen RC, Parisi JE, Dickson DW.Updated TDP-43 in Alzheimer's disease staging scheme[J].Acta Neuropathol, 2016, 131:571-585. [5] Nag S, Yu L, Boyle PA, Leurgans SE, Bennett DA, Schneider JA.TDP-43 pathology in anterior temporal pole cortex in aging and Alzheimer's disease[J].Acta Neuropathol Commun, 2018, 6:33. [6] Koga S, Sanchez-Contreras M, Josephs KA, Uitti RJ, Graff-Radford N, van Gerpen JA, Cheshire WP, Wszolek ZK, Rademakers R, Dickson DW.Distribution and characteristics of transactive response DNA binding protein 43 kDa pathology in progressive supranuclear palsy[J].Mov Disord, 2017, 32:246-255. [7] Uchino A, Takao M, Hatsuta H, Sumikura H, Nakano Y, Nogami A, Saito Y, Arai T, Nishiyama K, Murayama S.Incidence and extent of TDP-43 accumulation in aging human brain[J].Acta Neuropathol Commun, 2015, 3:35. [8] McAleese KE, Walker L, Erskine D, Thomas AJ, McKeith IG, Attems J.TDP-43 pathology in Alzheimer's disease, dementia with Lewy bodies and ageing[J].Brain Pathol, 2017, 27:472-479. [9] Nelson PT, Abner EL, Patel E, Anderson S, Wilcock DM, Kryscio RJ, Van Eldik LJ, Jicha GA, Gal Z, Nelson RS, Nelson BG, Gal J, Azam MT, Fardo DW, Cykowski MD.The amygdala as a locus of pathologic misfolding in neurodegenerative diseases[J].J Neuropathol Exp Neurol, 2018, 77:2-20. [10] Mackenzie IR, Neumann M, Baborie A, Sampathu DM, Du Plessis D, Jaros E, Perry RH, Trojanowski JQ, Mann DM, Lee VM.A harmonized classification system for FTLD-TDP pathology[J].Acta Neuropathol, 2011, 122:111-113. [11] Zhang X, Sun B, Wang X, Lu H, Shao F, Rozemuller AJM, Liang H, Liu C, Chen J, Huang M, Zhu K.Phosphorylated TDP-43 staging of primary age-related tauopathy[J].Neurosci Bull, 2019, 35:183-192. [12] The National Institute on Aging, and Reagan Institute Working Group on Diagnostic Criteria for the Neuropathological Assessment of Alzheimer's Disease.Consensus recommendations for the postmortem diagnosis of Alzheimer's disease[J].Neurobiol Aging, 1997, 18(4 Suppl):S1-2. [13] McKhann GM, Knopman DS, Chertkow H, Hyman BT, Jack CR Jr, Kawas CH, Klunk WE, Koroshetz WJ, Manly JJ, Mayeux R, Mohs RC, Morris JC, Rossor MN, Scheltens P, Carrillo MC, Thies B, Weintraub S, Phelps CH.The diagnosis of dementia due to Alzheimer's disease:recommendations from the National Institute on Aging-Alzheimer's Association Workgroups on diagnostic guidelines for Alzheimer's disease[J].Alzheimers Dement, 2011, 7:263-269. [14] Hughes AJ, Daniel SE, Kilford L, Lees AJ.Accuracy of clinical diagnosis of idiopathic Parkinson's disease:a clinico-pathological study of 100 cases[J].J Neurol Neurosurg Psychiatry, 1992, 55:181-184. [15] Hauw JJ, Daniel SE, Dickson D, Horoupian DS, Jellinger K, Lantos PL, McKee A, Tabaton M, Litvan I.Preliminary NINDS neuropathologic criteria for Steele-Richardson-Olszewski syndrome (progressive supranuclear palsy)[J].Neurology, 1994, 44:2015-2019. [16] Yokota O, Davidson Y, Bigio EH, Ishizu H, Terada S, Arai T, Hasegawa M, Akiyama H, Sikkink S, Pickering-Brown S, Mann DM.Phosphorylated TDP-43 pathology and hippocampal sclerosis in progressive supranuclear palsy[J].Acta Neuropathol, 2010, 120:55-66. [17] Amador-Ortiz C, Lin WL, Ahmed Z, Personett D, Davies P, Duara R, Graff-Radford NR, Hutton ML, Dickson DW.TDP-43 immunoreactivity in hippocampal sclerosis and Alzheimer's disease[J].Ann Neurol, 2007, 61:435-445. [18] Uryu K, Nakashima-Yasuda H, Forman MS, Kwong LK, Clark CM, Grossman M, Miller BL, Kretzschmar HA, Lee VM, Trojanowski JQ, Neumann M.Concomitant TAR-DNA-binding protein 43 pathology is present in Alzheimer disease and corticobasal degeneration but not in other tauopathies[J].J Neuropathol Exp Neurol, 2008, 67:555-564. [19] Arai T, Mackenzie IR, Hasegawa M, Nonoka T, Niizato K, Tsuchiya K, Iritani S, Onaya M, Akiyama H.Phosphorylated TDP-43 in Alzheimer's disease and dementia with Lewy bodies[J].Acta Neuropathol, 2009, 117:125-136. [20] Josephs KA, Whitwell JL, Weigand SD, Murray ME, Tosakulwong N, Liesinger AM, Petrucelli L, Senjem ML, Knopman DS, Boeve BF, Ivnik RJ, Smith GE, Jack CR Jr, Parisi JE, Petersen RC, Dickson DW.TDP-43 is a key player in the clinical features associated with Alzheimer's disease[J].Acta Neuropathol, 2014, 127:811-824. [21] Makkinejad N, Schneider JA, Yu J, Leurgans SE, Kotrotsou A, Evia AM, Bennett DA, Arfanakis K.Associations of amygdala volume and shape with transactive response DNA-binding protein 43(TDP-43) pathology in a community cohort of older adults[J].Neurobiol Aging, 2019, 77:104-111. [22] Nelson PT, Dickson DW, Trojanowski JQ, Jack CR, Boyle PA, Arfanakis K, Rademakers R, Alafuzoff I, Attems J, Brayne C, Coyle-Gilchrist ITS, Chui HC, Fardo DW, Flanagan ME, Halliday G, Hokkanen SRK, Hunter S, Jicha GA, Katsumata Y, Kawas CH, Keene CD, Kovacs GG, Kukull WA, Levey AI, Makkinejad N, Montine TJ, Murayama S, Murray ME, Nag S, Rissman RA, Seeley WW, Sperling RA, White CL 3rd, Yu L, Schneider JA.Limbic-predominant age-related TDP-43 encephalopathy (LATE):consensus working group report[J].Brain, 2019, 142:1503-1527. [23] Josephs KA, Dickson DW, Tosakulwong N, Weigand SD, Murray ME, Petrucelli L, Liesinger AM, Senjem ML, Spychalla AJ, Knopman DS, Parisi JE, Petersen RC, Jack CR Jr, Whitwell JL.Rates of hippocampal atrophy and presence of post-mortem TDP-43 in patients with Alzheimer's disease:a longitudinal retrospective study[J].Lancet Neurol, 2017, 16:917-924. [24] Nakashima-Yasuda H, Uryu K, Robinson J, Xie SX, Hurtig H, Duda JE, Arnold SE, Siderowf A, Grossman M, Leverenz JB, Woltjer R, Lopez OL, Hamilton R, Tsuang DW, Galasko D, Masliah E, Kaye J, Clark CM, Montine TJ, Lee VM, Trojanowski JQ.Co-morbidity of TDP-43 proteinopathy in Lewy body related diseases[J].Acta Neuropathol, 2007, 114:221-229. [25] Nascimento C, Di Lorenzo Alho AT, Bazan Conceição Amaral C, Leite REP, Nitrini R, Jacob-Filho W, Pasqualucci CA, Hokkanen SRK, Hunter S, Keage H, Kovacs GG, Grinberg LT, Suemoto CK.Prevalence of transactive response DNA-binding protein 43(TDP-43) proteinopathy in cognitively normal older adults:systematic review and meta-analysis[J].Neuropathol Appl Neurobiol, 2018, 44:286-297. [26] Robinson JL, Lee EB, Xie SX, Rennert L, Suh E, Bredenberg C, Caswell C, Van Deerlin VM, Yan N, Yousef A, Hurtig HI, Siderowf A, Grossman M, McMillan CT, Miller B, Duda JE, Irwin DJ, Wolk D, Elman L, McCluskey L, Chen-Plotkin A, Weintraub D, Arnold SE, Brettschneider J, Lee VM, Trojanowski JQ.Neurodegenerative disease concomitant proteinopathies are prevalent, age-related and APOE4-associated[J].Brain, 2018, 141:2181-2193. [27] Arnold SJ, Dugger BN, Beach TG.TDP-43 deposition in prospectively followed, cognitively normal elderly individuals:correlation with argyrophilic grains but not other concomitant pathologies[J].Acta Neuropathol, 2013, 126:51-57. [28] Kovacs GG, Milenkovic I, Wöhrer A, Höftberger R, Gelpi E, Haberler C, Hönigschnabl S, Reiner-Concin A, Heinzl H, Jungwirth S, Krampla W, Fischer P, Budka H.Non-Alzheimer neurodegenerative pathologies and their combinations are more frequent than commonly believed in the elderly brain:a community-based autopsy series[J].Acta Neuropathol, 2013, 126:365-384. [29] Nascimento C, Suemoto CK, Rodriguez RD, Alho AT, Leite RP, Farfel JM, Pasqualucci CA, Jacob-Filho W, Grinberg LT.Higher prevalence of TDP-43 proteinopathy in cognitively normal Asians:a clinicopathological study on a multiethnic sample[J].Brain Pathol, 2016, 26:177-185. [30] Geser F, Robinson JL, Malunda JA, Xie SX, Clark CM, Kwong LK, Moberg PJ, Moore EM, Van Deerlin VM, Lee VM, Arnold SE, Trojanowski JQ.Pathological 43-kDa transactivation response DNA-binding protein in older adults with and without severe mental illness[J].Arch Neurol, 2010, 67:1238-1250. |